Traditionally cancer research is initially performed in laboratories using techniques such as tissue culture and implanted cancer cells in mice.  Then there is a huge leap to take the drugs developed in the laboratory into clinical trials in humans with cancer.  Dis you know it takes on average 13 years to get a drug from the lab to human clinical use for cancer treatment?  It also costs an astonishing amount of money in the order of $1.3 billion.

Spontaneously developing diseases, such as cancer, in dogs and cats have long been studied to improve the understanding of similar diseases in humans. We call it translational oncology because the findings translate from one species to another.  Using this model to trial novel cancer therapies saves time and money as well as helping pets with cancer along the way.  This way we can identify effective treatments quickly, fine tune the technology and help people with cancer effectively reducing cost and development time.

Approximately half of human cancer patients undergo radiation therapy and many companion animals now have access to this treatment option. There are approximately 100 facilities in the Northern Hemisphere that are actively treating animals with radiation therapy.

Research funded by the Foundation has included:

  • Completion and publication of a prospective study into a novel radiation treatment protocol for feline oral squamous cell carcinoma.
  • Collaborative research with The University of Queensland and The Diamantina Institute into haemangiosarcoma (HSA) in dogs. This work has provided some valuable information about HSA proteomics.

User Login